Antitumor and Quantitative Structure Activity Relationship Study for Dihydropyridones Derived from Curcumin
Bahjat A. Saeed1, Kawkab Y. Saour2, Rita S. Elias1, Najim A. Al-Masoudi1 & Paola La Cola3 Show affiliations
- University of Basrah, Iraq
- University of Baghdad, Iraq
- University of Cagliari, Iraq
American Journal of Immunology, Volume 6, Issue 1, pp. 7–10 · doi.org/10.3844/ajisp.2010.7.10
Abstract
Problem statement: Pyridones are known to have variety of biological activities like antitumor, antibacterial, antiinflamatory and antimalarial activities. This study presented antitumor evaluation of dihydropyridones derived from curcumin, as well as curcumin for comparison. Approach: The compounds evaluated for a preliminary estimation of the in vitro tumor inhibiting activity against 11 of tumor cell lines by using Microculture Tetrazolium assay (MTT) method. The method is based on the metabolic reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. The cell lines of tumor subpanels were incubated within five concentrations (0.01-100 μg mL-1) of each tested compound for 48 h. Results: Antitumor biological activities represented as CC50 were within the range >100-17±1 against leukaemia (MT4). The CC50 values were found to increase with increasing chain length of the substituent on the nitrogen atom. Conclusion: Antitumor activities of the tested dihydropyridones can be enhanced by increasing chain length of the substituent on the nitrogen atom.
Licence and reuse
Free to read. This article carries the publisher’s copyright, as printed on it: © 2010 Science Publications. It is free to read; ask us before reusing it.
How to reuse this articleResponses (0)
About this article
Saeed, B. A., Saour, K. Y., Elias, R. S., Al-Masoudi, N. A. & Cola, P. L. (2010). Antitumor and Quantitative Structure Activity Relationship Study for Dihydropyridones Derived from Curcumin. American Journal of Immunology, 6(1), 7–10. https://doi.org/10.3844/ajisp.2010.7.10
- Licence
- © Science Publications
- Issue
- Volume 6, Issue 1
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record
